LPL Financial’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-9,876
Closed -$279K 5334
2024
Q3
$279K Buy
+9,876
New +$255K ﹤0.01% 4492
2024
Q2
Sell
-8,023
Closed -$263K 5058
2024
Q1
$263K Buy
8,023
+240
+3% +$7.66K ﹤0.01% 4307
2023
Q4
$257K Buy
+7,783
New +$220K ﹤0.01% 4211
2023
Q3
Sell
-7,895
Closed -$239K 4729
2023
Q2
$239K Sell
7,895
-12,952
-62% -$419K ﹤0.01% 4021
2023
Q1
$676K Sell
20,847
-3,565
-15% -$113K ﹤0.01% 3091
2022
Q4
$685K Sell
24,412
-742
-3% -$21.3K ﹤0.01% 2975
2022
Q3
$904K Buy
25,154
+3,005
+14% +$106K ﹤0.01% 2626
2022
Q2
$680K Buy
22,149
+1,439
+7% +$41.9K ﹤0.01% 2918
2022
Q1
$669K Buy
20,710
+1,605
+8% +$42K ﹤0.01% 2954
2021
Q4
$529K Buy
19,105
+10,691
+127% +$307K ﹤0.01% 3233
2021
Q3
$261K Buy
+8,414
New +$202K ﹤0.01% 3763
2018
Q3
Sell
-11,659
Closed -$245K 3248
2018
Q2
$245K Sell
11,659
-1,277
-10% -$24.2K ﹤0.01% 2832
2018
Q1
$184K Buy
+12,936
New +$185K ﹤0.01% 2977

Other funds holding EVH

LPL Financial's EVH Position: Q4 2024 in Review

LPL Financial sold out of Evolent Health (EVH) in Q4 2024, closing a stake of 9,876 shares — an estimated $279K sold.

LPL Financial first reported a position in EVH in Q1 2018 and held it in 13 quarters. The position peaked at $904K in Q3 2022. 240 funds tracked by Wall St. Rank hold EVH as of Q4 2024.

  • LPL Financial reported no remaining Evolent Health position as of Q4 2024 after selling out during the quarter.
  • LPL Financial sold 9,876 Evolent Health shares in Q4 2024, an estimated $279K.
  • LPL Financial first reported a position in Evolent Health in Q1 2018 and held it in 13 quarters.
  • LPL Financial's Evolent Health position peaked at $904K in Q3 2022.
  • 240 funds tracked by Wall St. Rank held Evolent Health as of Q4 2024.

Based on LPL Financial's 13F filing for Q4 2024, filed 11 Feb 2025.